Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Expert Review of Clinical Immunology|May 5, 2026
What is the best way to plan a 12-months clinical drug trial in JIA associated uveitisIvan Foeldvari, Ameenat Solebo, Sheila T Angeles-Han, et al.
Pediatric Rheumatology Online Journal|March 17, 2021
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter surveyMarco Cattalini, Sara Della Paolera, Fiammetta Zunica, et al.
Annals of the Rheumatic Diseases|March 30, 2018
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiativeTamas Constantin, Ivan Foeldvari, Jordi Anton, et al.
Clinical and Experimental Rheumatology|August 4, 2019
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus surveyAngelo Ravelli, Luigi Sinigaglia, Rolando Cimaz, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic ArthritisVanessa Cecchin, Maria Elisabetta Zannin, Daniele Ferrari, et al.
Seminars in Arthritis and Rheumatism|June 28, 2021
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest groupMelissa Oliver, Aruni Jayatilleke, Eveline Wu, et al.
Arthritis Care & Research|September 12, 2019
Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort StudyEllen Nordal, Angela Pistorio, Marite Rygg, et al.
Arthritis Care & Research|August 27, 2016
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic ArthritisPaula Frid, Ellen Nordal, Francesca Bovis, et al.
Rheumatology (Oxford, England)|January 20, 2024
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registryDaniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, et al.
Seminars in Arthritis and Rheumatism|January 18, 2022
The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohortMarta Bustaffa, Isabelle Koné-Paut, Seza Ozen, et al.
Pageof 20